The Therapeutic Monoclonal Antibody Product Market

The MAb market has continued to grow for the past several decades, with MAb products now the dominant product class within the biopharmaceutical market. Can we expect that growth to continue? See what the future holds for this market, based on findings from BDO’s bioTRAK database.

Read the Full Article